Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Net Cash Flow: 2012-2025

Historic Net Cash Flow for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $96.0 million.

  • Veracyte's Net Cash Flow rose 152.56% to $96.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.7 million, marking a year-over-year decrease of 41.66%. This contributed to the annual value of $23.7 million for FY2024, which is 61.84% down from last year.
  • Per Veracyte's latest filing, its Net Cash Flow stood at $96.0 million for Q3 2025, which was up 192.54% from $32.8 million recorded in Q2 2025.
  • Veracyte's Net Cash Flow's 5-year high stood at $96.0 million during Q3 2025, with a 5-year trough of -$163.6 million in Q3 2021.
  • For the 3-year period, Veracyte's Net Cash Flow averaged around $14.7 million, with its median value being $13.7 million (2023).
  • As far as peak fluctuations go, Veracyte's Net Cash Flow skyrocketed by 352.74% in 2023, and later tumbled by 661.51% in 2025.
  • Quarterly analysis of 5 years shows Veracyte's Net Cash Flow stood at $9.0 million in 2021, then plummeted by 284.33% to -$16.6 million in 2022, then soared by 182.55% to $13.7 million in 2023, then crashed by 349.10% to -$34.1 million in 2024, then skyrocketed by 152.56% to $96.0 million in 2025.
  • Its Net Cash Flow was $96.0 million in Q3 2025, compared to $32.8 million in Q2 2025 and -$52.9 million in Q1 2025.